China Resources Sanjiu Medical & Pharmaceutical Co Ltd

Research China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999.SZ) on Bullrun: market cap CNY 42.55B, P/E 13.0, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 42.55B; P/E is 13.0; dividend yield is 3.9%.

Peer valuation comparison

Latest P/E is 12.98x versus a Healthcare sector median of 21.75x (40.3% below).

Latest dividend yield is 3.93% versus a Healthcare sector median of 2.4% (63.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 42.55B13.05.7%1.46

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.46 CNY, yield 3.9%.

About China Resources Sanjiu Medical & Pharmaceutical Co Ltd

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market cap?

China Resources Sanjiu Medical & Pharmaceutical Co Ltd's market capitalization is CNY 42.55B.

What is China Resources Sanjiu Medical & Pharmaceutical Co Ltd's P/E ratio?

China Resources Sanjiu Medical & Pharmaceutical Co Ltd's price-to-earnings (P/E) ratio is 13.0.

Does China Resources Sanjiu Medical & Pharmaceutical Co Ltd pay a dividend?

China Resources Sanjiu Medical & Pharmaceutical Co Ltd has a dividend yield of 3.9%.

What does China Resources Sanjiu Medical & Pharmaceutical Co Ltd do?

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally.